University of Illinois Chicago — Chicago, Illinois

University of Illinois Chicago is a clinical research site located in Chicago, Illinois, United States 60607.

Crixeo Health Trust Score: 89/100 (GOOD). This profile has not yet been claimed by the site owner.

University of Illinois Chicago has participated in 78 clinical trials with 44 currently active.

Therapeutic areas: Post Operative Pain, B Cell Precursor Acute Lymphoblastic Leukemia, Stroke.

Sponsors: Rutgers, The State University of New Jersey, Amgen, University of Illinois at Chicago.

Sponsor Feasibility Report

Trust Score: 89/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Illinois Chicago?

University of Illinois Chicago has a Crixeo Trust Score of 89/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Illinois Chicago conducted?

University of Illinois Chicago has 78 clinical trials on record, with 44 currently active. Their work covers Post Operative Pain, B Cell Precursor Acute Lymphoblastic Leukemia, Stroke.

Is University of Illinois Chicago accredited by Crixeo Health?

Yes — University of Illinois Chicago holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about University of Illinois Chicago?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.